Publication:
The primacy of public health considerations in defining poor quality medicines

Simple item page
dc.contributor.authorPaul N. Newtonen_US
dc.contributor.authorAbdinasir A. Aminen_US
dc.contributor.authorChris Birden_US
dc.contributor.authorPhillip Passmoreen_US
dc.contributor.authorGraham Dukesen_US
dc.contributor.authorGöran Tomsonen_US
dc.contributor.authorBright Simonsen_US
dc.contributor.authorRoger Bateen_US
dc.contributor.authorPhilippe J. Guerinen_US
dc.contributor.authorNicholas J. Whiteen_US
dc.contributor.otherMahosot Hospitalen_US
dc.contributor.otherNuffield Department of Clinical Medicineen_US
dc.contributor.otherUniversity of Oxforden_US
dc.contributor.otherPopulation Services Internationalen_US
dc.contributor.otherWellcome Trusten_US
dc.contributor.otherCurtin Universityen_US
dc.contributor.otherUniversitetet i Osloen_US
dc.contributor.otherKarolinska Instituteten_US
dc.contributor.otherIMANI Center for Policy and Educationen_US
dc.contributor.otherAmerican Enterprise Instituteen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-05-03T08:22:39Z
dc.date.available2018-05-03T08:22:39Z
dc.date.issued2011-12-01en_US
dc.identifier.citationPLoS Medicine. Vol.8, No.12 (2011)en_US
dc.identifier.doi10.1371/journal.pmed.1001139en_US
dc.identifier.issn15491676en_US
dc.identifier.issn15491277en_US
dc.identifier.other2-s2.0-84855175196en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/12216
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84855175196&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleThe primacy of public health considerations in defining poor quality medicinesen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84855175196&origin=inwarden_US

Files

Collections

Scopus 2011-2015